2012 HSCI call for proposals – Kidney Program pilot grants

December 16, 2011

The Harvard Stem Cell Institute (HSCI) Kidney Program invites applications for up to two Program Grant and up to two Pilot Grants for 2012. The purpose of this funding program is to provide resources for research in adult kidney disease with the goal of developing new therapeutic strategies. As such, a critical component is the translatability of the research project. This may take many forms, and does not require human subjects research, however thought should be given as to how funds will be best used to ultimately bring new therapies to the clinic. Preference will be given to projects focused on the adult kidney, for which current funding sources are not available and where clinical potential is high.

2011 end of year giving

December 5, 2011

If you are considering giving a gift to HSCI in tax year 2011, there are a few factors to keep in mind to make sure that Harvard is able to give you a tax receipt for calendar year 2011 instead of 2012.  Mutual funds must be received in Harvard’s account no later than 12/12/2011.  If you are sending a check, please make sure that the envelope is postmarked no later than 12/31/2011, or, if you are using a service other than US Mail, that the package arrives at Harvard no later than 12/31/2011.  Credit card donations must be charged to your account no later than 12/31/2011.  …

Stem cell lessons: Insights on SCNT in studies, commentary

October 5, 2011

Five years after Harvard researchers first received institutional permission to attempt to produce stem cell lines via somatic cell nuclear transfer (SCNT), a young scientist who worked in the Harvard program as a postdoctoral fellow has succeeded in using the process — known as therapeutic cloning — to produce a stem cell line containing the genes of a patient with type 1 diabetes.

Doug Melton named a University Professor

September 28, 2011

Doug Melton, co-founding director of the Harvard Stem Cell Institute (HSCI), a leading stem cell and regenerative biologist, and one of the driving forces behind Harvard's ascendency to world leadership in the field, has been named a University Professor, Harvard's highest professorial distinction.

From skin cells to motor neurons: researchers find success with direct cellular reprogramming

August 29, 2011

A team of Harvard stem cell researchers has succeeded in reprogramming adult mouse skin cells directly into the type of motor neurons damaged in amyotrophic lateral sclerosis (ALS), best known as Lou Gehrig’s disease, and spinal muscular atrophy (SMA). These new cells, which researchers are calling induced motor neurons (iMNs), can be used to study the development of the paralyzing diseases and to develop treatments for them.

Call for proposals: Cancer Program pilot grants

June 7, 2011

Program Overview:
The Harvard Stem Cell Institute (HSCI) Cancer Program invites applications for pilot grants funding for 2011. The purpose of this funding program is to provide resources for innovative projects by investigators in the field of cancer stem cell biology, including basic, translational or clinical research. This funding is for groundbreaking, innovative, high- impact research projects that could fundamentally enhance biomedical research.  Particularly welcomed are applications that promote the Program mission: to identify critical genes and pathways that sufficiently distinguish cancer from normal stem cells and hence serve as candidate targets for therapy.



April 18, 2011